Company profile: Celladon
1.1 - Company Overview
Company description
- Provider of biotechnology focused on developing molecular therapies for the treatment of heart failure.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Celladon
Ventripoint Diagnostics
HQ: Canada
Website
- Description: Provider of knowledge-based heart analysis software. Offerings include VMS+, which creates accurate 3D heart models from 2D echocardiograms and provides cardiac metrics for all four chambers within minutes, and 3D Echo and MRI software installable on any workstation to generate 3D chamber models from commercially available 3D echo or MRI with reproducible, accurate volumetric measurements and ejection fractions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ventripoint Diagnostics company profile →
Carmat
HQ: France
Website
- Description: Provider of biocompatible, auto-regulated bioprosthetic total artificial hearts, including right and left ventricles designed to be as close as possible to the human heart; offers Aeson as an alternative therapeutic option for patients with advanced biventricular heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carmat company profile →
Baylis Medical
HQ: Canada
Website
- Description: Provider of high-technology cardiology, endovascular, and oncology products, specializing in RF transseptal access and puncture systems that create controlled perforations in cardiac and vascular tissues. Products include NRG RF Transseptal Kit and Needle, SupraCross RF Transseptal Solution, VersaCross steerable access solutions, and SureFlex steerable guiding sheaths.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Baylis Medical company profile →
BioTrace Medical
HQ: United States
Website
- Description: Provider of temporary cardiac pacing solutions, including the Tempo Lead, a temporary pacing lead designed to minimize the risk of myocardial perforation, provide stable pacing, and enable early patient mobilization after procedures such as TAVR, aiming to improve patient outcomes and reduce hospital costs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioTrace Medical company profile →
CardioFocus
HQ: United States
Website
- Description: Provider of cardiac ablation technologies, including the HeartLight X3 laser balloon catheter for pulmonary vein isolation in atrial fibrillation with direct visualization, titratable laser energy, and compliant balloon technology, and the CENTAURI system leveraging Pulsed Electric Field for intracardiac ablation, compatible with existing mapping systems and focal ablation catheters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioFocus company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Celladon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Celladon
2.2 - Growth funds investing in similar companies to Celladon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Celladon
4.2 - Public trading comparable groups for Celladon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →